Bank of New York Mellon
WVE icon

Bank of New York Mellon’s Wave Life Sciences WVE Stock Holding History

Bank of New York Mellon’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
416,579
+55,375
+15% +$367K ﹤0.01% 2835
2026
Q1 		$2.62M Buy
361,204
+39,759
+12% +$518K ﹤0.01% 2673
2025
Q4 		$5.46M Buy
321,445
+23,589
+8% +$240K ﹤0.01% 2273
2025
Q3 		$2.18M Buy
297,856
+8,574
+3% +$69.4K ﹤0.01% 2757
2025
Q2 		$1.88M Buy
289,282
+42,031
+17% +$278K ﹤0.01% 2781
2025
Q1 		$2M Buy
247,251
+2,278
+0.9% +$24.9K ﹤0.01% 2687
2024
Q4 		$3.03M Buy
244,973
+43,143
+21% +$576K ﹤0.01% 2559
2024
Q3 		$1.66M Sell
201,830
-23,572
-10% -$141K ﹤0.01% 2847
2024
Q2 		$1.12M Buy
225,402
+27,524
+14% +$157K ﹤0.01% 3123
2024
Q1 		$1.22M Buy
197,878
+17,460
+10% +$87.4K ﹤0.01% 3041
2023
Q4 		$911K Buy
180,418
+2,894
+2% +$15.5K ﹤0.01% 3235
2023
Q3 		$1.02M Buy
177,524
+1,359
+0.8% +$6.2K ﹤0.01% 3131
2023
Q2 		$641K Buy
176,165
+150,179
+578% +$607K ﹤0.01% 3459
2023
Q1 		$113K Buy
25,986
+354
+1% +$1.62K ﹤0.01% 4053
2022
Q4 		$179K Buy
25,632
+5,169
+25% +$23.8K ﹤0.01% 4004
2022
Q3 		$74K Sell
20,463
-3,705
-15% -$12.3K ﹤0.01% 4256
2022
Q2 		$79K Sell
24,168
-102,942
-81% -$198K ﹤0.01% 4277
2022
Q1 		$254K Sell
127,110
-2,013
-2% -$4.93K ﹤0.01% 4110
2021
Q4 		$406K Buy
129,123
+4,270
+3% +$17.7K ﹤0.01% 3924
2021
Q3 		$612K Buy
124,853
+17,420
+16% +$106K ﹤0.01% 3688
2021
Q2 		$715K Sell
107,433
-14,901
-12% -$97.4K ﹤0.01% 3597
2021
Q1 		$686K Buy
122,334
+1,792
+1% +$17.2K ﹤0.01% 3526
2020
Q4 		$949K Buy
120,542
+34,570
+40% +$290K ﹤0.01% 3273
2020
Q3 		$730K Buy
85,972
+3,707
+5% +$40.6K ﹤0.01% 3301
2020
Q2 		$857K Sell
82,265
-4,774
-5% -$44.9K ﹤0.01% 3191
2020
Q1 		$815K Sell
87,039
-2,648
-3% -$22.6K ﹤0.01% 3110
2019
Q4 		$718K Buy
89,687
+3,494
+4% +$85.7K ﹤0.01% 3397
2019
Q3 		$1.77M Sell
86,193
-4,292
-5% -$98.4K ﹤0.01% 2814
2019
Q2 		$2.36M Buy
90,485
+7,769
+9% +$218K ﹤0.01% 2722
2019
Q1 		$3.21M Buy
82,716
+10,074
+14% +$409K ﹤0.01% 2543
2018
Q4 		$3.05M Buy
72,642
+2,768
+4% +$123K ﹤0.01% 2530
2018
Q3 		$3.49M Buy
69,874
+659
+1% +$29.7K ﹤0.01% 2565
2018
Q2 		$2.65M Sell
69,215
-10,417
-13% -$448K ﹤0.01% 2699
2018
Q1 		$3.19M Buy
79,632
+22,244
+39% +$935K ﹤0.01% 2562
2017
Q4 		$2.02M Buy
57,388
+7,695
+15% +$224K ﹤0.01% 2833
2017
Q3 		$1.08M Buy
49,693
+2,589
+5% +$52K ﹤0.01% 3175
2017
Q2 		$876K Buy
47,104
+15,754
+50% +$340K ﹤0.01% 3321
2017
Q1 		$862K Buy
31,350
+279
+0.9% +$7.79K ﹤0.01% 3316
2016
Q4 		$813K Buy
31,071
+9,728
+46% +$316K ﹤0.01% 3369
2016
Q3 		$693K Buy
21,343
+2,718
+15% +$64.2K ﹤0.01% 3373
2016
Q2 		$385K Buy
+18,625
New +$290K ﹤0.01% 3644

Other funds holding WVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon's WVE Position: Q2 2026 in Review

Bank of New York Mellon increased its Wave Life Sciences (WVE) stake by 15% in Q2 2026, buying an estimated $367K and bringing the position to 416,579 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Bank of New York Mellon first reported a position in WVE in Q2 2016 and has held it in 41 quarters since. The position peaked at $5.46M in Q4 2025. 96 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Bank of New York Mellon held 416,579 shares of Wave Life Sciences worth $2.42M as of Q2 2026.
  • Bank of New York Mellon bought 55,375 Wave Life Sciences shares in Q2 2026, an estimated $367K.
  • Wave Life Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2835 holding.
  • Bank of New York Mellon first reported a position in Wave Life Sciences in Q2 2016 and has held it in 41 quarters since.
  • Bank of New York Mellon's Wave Life Sciences position peaked at $5.46M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.